Allergic rhinitis and its impact on asthma update (ARIA 2008)--western and Asian-Pacific perspective.
The prevalence of allergic diseases such as allergic rhinitis (AR) and asthma is markedly increasing worldwide as societies adopt western life styles. Allergic sensitization is an important risk factor for asthma and AR, and asthma often co-exists with AR. An estimated 300 million people worldwide have asthma, about 50% of whom live in developing countries and about 400 million people suffer from AR. Yet, AR is often under-diagnosed and under-treated due to a lack of appreciation of the disease burden and its impact on quality of life, as well as its social impact at school and at the workplace. However, AR with or without asthma is a huge economic burden. Thus, there was clearly a need for a global evidence-based document which would highlight the interactions between the upper and lower airways including diagnosis, epidemiology, common risk factors, management and prevention. The Allergic Rhinitis and its Impact on Asthma (ARIA) document was first published in 2001 as a state-of-the-art guideline for the specialist, the general practitioner and other health care professionals. Subsequent new evidence regarding the pathomechanisms, new drugs and increased knowledge have resulted in the publication of the ARIA 2008 update. The present review summarizes the ARIA update with particular emphasis on the current status of AR and asthma in the Asia-Pacific region and discusses the Western and Asian perspective.
Pawankar
Ruby
R
Nippon Medical School, Tokyo, Japan. rpawankar@gmail.com
Bunnag
Chaweewan
C
Chen
Yuzhi
Y
Fukuda
Takeshi
T
Kim
You-Young
YY
Le
Lan Thi Tuyet
LT
Huong
Le Thi Thu
le TT
O'Hehir
Robyn E
RE
Ohta
Ken
K
Vichyanond
Pakit
P
Wang
De-Yun
DY
Zhong
Nanshan
N
Khaltaev
Nikolai
N
Bousquet
Jean
J
D000465:Algorithms; D001208:Asia; D001249:Asthma / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D015897:Comorbidity; D003888:Desensitization, Immunologic; D019317:Evidence-Based Medicine; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D010140:Pacific Ocean; D017410:Practice Guidelines as Topic; D015995:Prevalence; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D019366:Western World
D020024:Leukotriene Antagonists